Table 2.
Secondary outcomes values are expressed as pooled proportions and 95% confidence intervals (95% CI). I2, heterogeneity; HLOS, hospital length of stay
| Outcomes | Proportion (95% CI) | I2 (95% CI) | No. of studies |
|---|---|---|---|
| Cardiovascular complications | 9.0% (4.1–16.0%) | 68% (26–95%) | 14 |
| Pulmonary complications | 14.1% (8.0–22.0%) | 27% (5.3–49.0%) | 18 |
| Anastomotic leak | 1.4% (0.8–2.2%) | 31% (0.0–53.1%) | 17 |
| Reoperation | 12.0% (8.0–17.2%) | 0.0% (0.0–78%) | 22 |
| Conversion to open | 9.2% (4.5–21.0%) | 0.0% (0.0–67%) | 18 |
| Recurrence | 16.0% (13–22.6%) | 0.0% (0.0–26.1%) | 22 |
| HLOS (days) | 15.93 (10.4–21.4%) | 93% (76.2–99.4%) | 16 |